MEP Lamberts Says AstraZeneca Treating EU `Unfairly'

Philip Lombard, a member of the European Parliament, discusses the EU's challenges with vaccine rollout, focusing on issues with AstraZeneca's delivery commitments. He refutes claims of nationalism and highlights discrepancies in how AstraZeneca treats the EU compared to other customers. The discussion touches on potential double-booking of vaccine supplies and the impact of Brexit on the UK's efficient vaccine rollout. Lombard emphasizes that the EU is the damaged party due to AstraZeneca's actions, not due to global supply issues.

What concerns were raised about the European Union's vaccine rollout?

What accusations were made regarding nationalism in the context of the vaccine rollout?

How did the speaker describe the relationship between the European Union and the pharmaceutical company mentioned?

What were the key issues identified with the pharmaceutical company's delivery promises?

What was the speaker's perspective on AstraZeneca's commitments to different customers?

What implications did the speaker suggest Brexit might have on vaccine distribution?

In what ways did the speaker suggest that AstraZeneca's performance differed between the UK and the EU?